Highlander Capital Management’s Rosetta Genomics Ltd. ROSG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-8,647
| Closed | -$1K | – | 629 |
|
|
2021
Q2 | $1K | Hold |
8,647
| – | – | ﹤0.01% | 599 |
|
|
2021
Q1 | $1K | Hold |
8,647
| – | – | ﹤0.01% | 609 |
|
|
2020
Q4 | $0 | Hold |
8,647
| – | – | ﹤0.01% | 644 |
|
|
2020
Q3 | $0 | Buy |
+8,647
| New | – | ﹤0.01% | 632 |
|
|
2020
Q2 | – | Sell |
-8,647
| Closed | – | – | 646 |
|
|
2020
Q1 | $0 | Buy |
+8,647
| New | – | ﹤0.01% | 669 |
|
|
2019
Q3 | – | Sell |
-8,647
| Closed | – | – | 701 |
|
|
2019
Q2 | $0 | Hold |
8,647
| – | – | ﹤0.01% | 724 |
|
|
2019
Q1 | $0 | Buy |
+8,647
| New | – | ﹤0.01% | 747 |
|
|
2018
Q4 | – | Sell |
-8,647
| Closed | – | – | 758 |
|
|
2018
Q3 | $0 | Hold |
8,647
| – | – | ﹤0.01% | 779 |
|
|
2018
Q2 | $0 | Hold |
8,647
| – | – | ﹤0.01% | 799 |
|
|
2018
Q1 | $3K | Hold |
8,647
| – | – | ﹤0.01% | 709 |
|
|
2017
Q4 | $5K | Sell |
8,647
-12,136
| -58% | -$9.52K | ﹤0.01% | 668 |
|
|
2017
Q3 | $22K | Sell |
20,783
-11,514
| -36% | -$20.4K | 0.02% | 487 |
|
|
2017
Q2 | $76K | Sell |
32,297
-626
| -2% | -$1.39K | 0.06% | 286 |
|
|
2017
Q1 | $97K | Sell |
32,923
-534
| -2% | -$2.88K | 0.08% | 256 |
|
|
2016
Q4 | $170K | Sell |
33,457
-6,888
| -17% | -$52.7K | 0.15% | 168 |
|
|
2016
Q3 | $402K | Sell |
40,345
-2,784
| -6% | -$33.9K | 0.36% | 75 |
|
|
2016
Q2 | $595K | Sell |
43,129
-508
| -1% | -$7.24K | 0.54% | 42 |
|
|
2016
Q1 | $570K | Buy |
43,637
+3,646
| +9% | +$46.5K | 0.53% | 44 |
|
|
2015
Q4 | $593K | Buy |
39,991
+19,567
| +96% | +$422K | 0.55% | 41 |
|
|
2015
Q3 | $605K | Buy |
20,424
+3,067
| +18% | +$105K | 0.57% | 35 |
|
|
2015
Q2 | $706K | Buy |
17,357
+3,835
| +28% | +$164K | 0.63% | 34 |
|
|
2015
Q1 | $495K | Buy |
13,522
+3,229
| +31% | +$122K | 0.43% | 60 |
|
|
2014
Q4 | $279K | Buy |
10,293
+791
| +8% | +$25.7K | 0.24% | 111 |
|
|
2014
Q3 | $402K | Buy |
9,502
+834
| +10% | +$37.9K | 0.38% | 70 |
|
|
2014
Q2 | $451K | Sell |
8,668
-417
| -5% | -$20.7K | 0.41% | 64 |
|
|
2014
Q1 | $543K | Buy |
+9,085
| New | +$469K | 0.51% | 47 |
|
Highlander Capital Management's ROSG Position: Q3 2021 in Review
Highlander Capital Management sold out of Rosetta Genomics Ltd. (ROSG) in Q3 2021, closing a stake of 8,647 shares — an estimated $1K sold.
Highlander Capital Management first reported a position in ROSG in Q1 2014 and held it in 26 quarters. The position peaked at $706K in Q2 2015. 0 funds tracked by Wall St. Rank hold ROSG as of Q3 2021.
- Highlander Capital Management reported no remaining Rosetta Genomics Ltd. position as of Q3 2021 after selling out during the quarter.
- Highlander Capital Management sold 8,647 Rosetta Genomics Ltd. shares in Q3 2021, an estimated $1K.
- Highlander Capital Management first reported a position in Rosetta Genomics Ltd. in Q1 2014 and held it in 26 quarters.
- Highlander Capital Management's Rosetta Genomics Ltd. position peaked at $706K in Q2 2015.
- 0 funds tracked by Wall St. Rank held Rosetta Genomics Ltd. as of Q3 2021.
Based on Highlander Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.